Engineering chemoattractant gradients using chemokine-releasing polysaccharide microspheres

Biomaterials

Volumn 32, Issue 21, 2011, Pages 4903-4913

  Wang, Yana ^a   Irvine, Darrell J ^a,b,c,d  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Alginate; Chemokine; Chemotaxis; Hydrogel; Leukocyte; Microsphere

Indexed keywords

ALGINATE HYDROGELS; BIOLOGICAL PROCESS; CATIONIC CHARGES; CHEMOATTRACTANT GRADIENTS; CHEMOATTRACTANTS; CHEMOKINE; CHEMOKINES; CHEMOTAXIS; COLLAGEN GELS; ELECTROSTATIC ADSORPTION; GLYCOSAMINOGLYCANS; HOST CELLS; IMMUNE CELLS; IN-VITRO; IN-VIVO; LEUKOCYTE; MICROENVIRONMENTS; SINGLE CELLS; TEMPORAL CONCENTRATIONS; VERSATILE SYSTEM;

ADSORPTION; BIOCHEMISTRY; CELLS; HYDROGELS; PEPTIDES; PHYSIOLOGY; TISSUE; TISSUE ENGINEERING;

MICROSPHERES;

ALGINIC ACID; CHEMOATTRACTANT; CHEMOKINE; COLLAGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOSAMINOGLYCAN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MICROSPHERE; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

ADSORPTION; ARTICLE; BIOENGINEERING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROGEL; MATERIALS TESTING; PRIORITY JOURNAL;

ADSORPTION; ALGINATES; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; CHEMOKINE CCL19; CHEMOKINE CCL21; CHEMOKINE CXCL10; CHEMOKINE CXCL12; CHEMOKINES; CHEMOTACTIC FACTORS; CHEMOTAXIS; DRUG CARRIERS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MATERIALS TESTING; MICROSPHERES; T-LYMPHOCYTES;

EID: 79955752390     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.027     Document Type: Article

References (79)

1. Campbell D.J., Kim C.H., Butcher E.C. Chemokines in the systemic organization of immunity. Immunol Rev 2003, 195:58-71.
2. Kim C.H., Broxmeyer H.E. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 1999, 65:6-15.
3. Olson T.S., Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002, 283:R7-R28.
4. Wei S.H., Parker I., Miller M.J., Cahalan M.D. A stochastic view of lymphocyte motility and trafficking within the lymph node. Immunol Rev 2003, 195:136-159.
5. Miyasaka M., Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004, 4:360-370.
6. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004, 22:891-928.
7. Devreotes P.N., Zigmond S.H. Chemotaxis in eukaryotic cells: a focus on leukocytes and dictyostelium. Annu Rev Cell Biol 1988, 4:649-686.
8. Lauffenburger D.A., Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 1996, 84:359-369.
9. Stachowiak A.N., Wang Y., Huang Y.C., Irvine D.J. Homeostatic lymphoid chemokines synergize with adhesion ligands to trigger T and B lymphocyte chemokinesis. J Immunol 2006, 177:2340-2348.
10. Houshmand P., Zlotnik A. Therapeutic applications in the chemokine superfamily. Curr Opin Chem Biol 2003, 7:457-460.
11. Toka F.N., Gierynska M., Rouse B.T. Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1. J Virol 2003, 77:12742-12752.
12. Kirk C.J., Hartigan-O'Connor D., Mule J.J. The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally. Cancer Res 2001, 61:8794-8802.
13. Guiducci C., Di Carlo E., Parenza M., Hitt M., Giovarelli M., Musiani P., et al. Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor. J Immunol 2004, 172:4026-4036.
14. Yang S.C., Hillinger S., Riedl K., Zhang L., Zhu L., Huang M., et al. Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clin Cancer Res 2004, 10:2891-2901.
15. Thanarajasingam U., Sanz L., Diaz R., Qiao J., Sanchez-Perez L., Kottke T., et al. Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy. Cancer Res 2007, 67:300-308.
16. Guiducci C., Vicari A.P., Sangaletti S., Trinchieri G., Colombo M.P. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res 2005, 65:3437-3446.
17. Kumamoto T., Huang E.K., Paek H.J., Morita A., Matsue H., Valentini R.F., et al. Induction of tumor-specific protective immunity by in situ langerhans cell vaccine. Nat Biotechnol 2002, 20:64-69.
18. Singh A., Suri S., Roy K. In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells. Biomaterials 2009, 30:5187-5200.
19. Kress H., Park J.G., Mejean C.O., Forster J.D., Park J., Walse S.S., et al. Cell stimulation with optically manipulated microsources. Nat Methods 2009, 6:905-909.
20. Zhao X., Jain S., Benjamin Larman H., Gonzalez S., Irvine D.J. Directed cell migration via chemoattractants released from degradable microspheres. Biomaterials 2005, 26:5048-5063.
21. Tamber H., Johansen P., Merkle H.P., Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005, 57:357-376.
22. van de Weert M., Hennink W.E., Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 2000, 17:1159-1167.
23. Zhu G., Mallery S.R., Schwendeman S.P. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nat Biotechnol 2000, 18:52-57.
24. Hori Y., Winans A.M., Irvine D.J. Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. Acta Biomater 2009, 5:969-982.
25. Hori Y., Winans A.M., Huang C.C., Horrigan E.M., Irvine D.J. Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy. Biomaterials 2008, 29:3671-3682.
26. Proudfoot A.E., Handel T.M., Johnson Z., Lau E.K., LiWang P., Clark-Lewis I., et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A 2003, 100:1885-1890.
27. Wagner L., Yang O.O., Garcia-Zepeda E.A., Ge Y., Kalams S.A., Walker B.D., et al. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 1998, 391:908-911.
28. Ali S., Robertson H., Wain J.H., Isaacs J.D., Malik G., Kirby J.A. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. J Immunol 2005, 175:1257-1266.
29. Edelman E.R., Mathiowitz E., Langer R., Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991, 12:619-626.
30. Mumper R.J., Hoffman A.S., Puolakkainen P.A., Bouchard L.S., Gombotz W.R. Calcium-alginate beads for the oral delivery of transforming growth factor-β1 (TGF-β1): stabilization of TGF-β1 by the addition of polyacrylic acid within acid-treated beads. J Control Release 1994, 30:241-251.
31. Maysinger D., Jalsenjak I., Cuello A.C. Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions. Neurosci Lett 1992, 140:71-74.
32. Liao I.C., Wan A.C., Yim E.K., Leong K.W. Controlled release from fibers of polyelectrolyte complexes. J Control Release 2005, 104:347-358.
33. Yang D., Chen Q., Hoover D.M., Staley P., Tucker K.D., Lubkowski J., et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003, 74:448-455.
34. Crank J. The mathematics of diffusion 1975, Clarendon Press, Oxford.
35. Lauffenburger D.A., Tranquillo R.T., Zigmond S.H. Concentration gradients of chemotactic factors in chemotaxis assays. Methods Enzymol 1988, 162:85-101.
36. Tanford C. Physcial chemistry of macromolecules 1961, Wiley, New York.
37. Zigmond S.H. Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors. J Cell Biol 1977, 75:606-616.
38. Campbell J.J., Bowman E.P., Murphy K., Youngman K.R., Siani M.A., Thompson D.A., et al. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol 1998, 141:1053-1059.
39. Willimann K., Legler D.F., Loetscher M., Roos R.S., Delgado M.B., Clark-Lewis I., et al. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol 1998, 28:2025-2034.
40. Yoshida R., Nagira M., Imai T., Baba M., Takagi S., Tabira Y., et al. EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC. Int Immunol 1998, 10:901-910.
41. Burns J.M., Summers B.C., Wang Y., Melikian A., Berahovich R., Miao Z., et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006, 203:2201-2213.
42. Balabanian K., Lagane B., Infantino S., Chow K.Y., Harriague J., Moepps B., et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005, 280:35760-35766.
43. Moghe P.V., Nelson R.D., Tranquillo R.T. Cytokine-stimulated chemotaxis of human neutrophils in a 3-D conjoined fibrin gel assay. J Immunol Methods 1995, 180:193-211.
44. Hori Y., Stern P.J., Hynes R.O., Irvine D.J. Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy. Biomaterials 2009, 30:6757-6767.
45. Tanaka Y., Adams D.H., Hubscher S., Hirano H., Siebenlist U., Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 1993, 361:79-82.
46. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., Borlat F., Clark-Lewis I., Power C.A., et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 1997, 36:13570-13578.
47. Patel D.D., Koopmann W., Imai T., Whichard L.P., Yoshie O., Krangel M.S. Chemokines have diverse abilities to form solid phase gradients. Clin Immunol 2001, 99:43-52.
48. Nakano H., Tamura T., Yoshimoto T., Yagita H., Miyasaka M., Butcher E.C., et al. Genetic defect in T lymphocyte-specific homing into peripheral lymph nodes. Eur J Immunol 1997, 27:215-221.
49. Stein J.V., Rot A., Luo Y., Narasimhaswamy M., Nakano H., Gunn M.D., et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 2000, 191:61-76.
50. Worbs T., Mempel T.R., Bolter J., von Andrian U.H., Forster R. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med 2007, 204:489-495.
51. Forster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
52. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999, 189:451-460.
53. Hirose J., Kawashima H., Willis M.S., Springer T.A., Hasegawa H., Yoshie O., et al. Chondroitin sulfate B exerts its inhibitory effect on secondary lymphoid tissue chemokine (SLC) by binding to the C-terminus of SLC. Biochim Biophys Acta 2002, 1571:219-224.
54. Christopherson K.W., Campbell J.J., Travers J.B., Hromas R.A. Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration. J Pharmacol Exp Ther 2002, 302:290-295.
55. Castro G.R., Chen J., Panilaitis B., Kaplan D.L. Emulsan-alginate beads for protein adsorption. J Biomater Sci Polym Ed 2009, 20:411-426.
56. Admason A.W. Physical chemistry of surfaces 1976, John Wiley and Sons, New York.
57. Kwon G.S., Bae Y.H., Cremers H., Feijen J., Kim S.W. Release of proteins via ion exchange from albumin-heparin microspheres. J Control Release 1992, 22:83-94.
58. Tayalia P., Mazur E., Mooney D.J. Controlled architectural and chemotactic studies of 3D cell migration. Biomaterials 2011, 32:2634-2641.
59. Schumann K., Lammermann T., Bruckner M., Legler D.F., Polleux J., Spatz J.P., et al. Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity 2010, 32:703-713.
60. Kim C.H., Pelus L.M., White J.R., Applebaum E., Johanson K., Broxmeyer H.E. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol 1998, 160:2418-2424.
61. Ngo V.N., Tang H.L., Cyster J.G. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 1998, 188:181-191.
62. Link A., Vogt T.K., Favre S., Britschgi M.R., Acha-Orbea H., Hinz B., et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007, 8:1255-1265.
63. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 184:1101-1109.
64. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997, 61:246-257.
65. Taub D.D., Lloyd A.R., Wang J.M., Oppenheim J.J., Kelvin D.J. The effects of human recombinant MIP-1 alpha, MIP-1 beta, and RANTES on the chemotaxis and adhesion of T cell subsets. Adv Exp Med Biol 1993, 351:139-146.
66. Herzmark P., Campbell K., Wang F., Wong K., El-Samad H., Groisman A., et al. Bound attractant at the leading vs. the trailing edge determines chemotactic prowess. P Natl Acad Sci USA 2007, 104:13349-13354.
67. Lin F., Butcher E.C. Modeling the role of homologous receptor desensitization in cell gradient sensing. J Immunol 2008, 181:8335-8343.
68. Wee S., Gombotz W.R. Protein release from alginate matrices. Adv Drug Deliv Rev 1998, 31:267-285.
69. Kong H.J., Mooney D.J. Polysaccharide hydrogels in tissue engineering. Polysaccharides 2005, Marcel & Dekker. 2nd ed.
70. Chieppa M., Bianchi G., Doni A., Del Prete A., Sironi M., Laskarin G., et al. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 2003, 171:4552-4560.
71. Lebre M.C., Burwell T., Vieira P.L., Lora J., Coyle A.J., Kapsenberg M.L., et al. Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation. Immunol Cell Biol 2005, 83:525-535.
72. Oynebraten I., Bakke O., Brandtzaeg P., Johansen F.E., Haraldsen G. Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. Blood 2004, 104:314-320.
73. Francis K., Palsson B.O. Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion. Proc Natl Acad Sci U S A 1997, 94:12258-12262.
74. Kohout T.A., Nicholas S.L., Perry S.J., Reinhart G., Junger S., Struthers R.S. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem 2004, 279:23214-23222.
75. Otero C., Groettrup M., Legler D.F. Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation. J Immunol 2006, 177:2314-2323.
76. Haribabu B., Richardson R.M., Fisher I., Sozzani S., Peiper S.C., Horuk R., et al. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem 1997, 272:28726-28731.
77. Signoret N., Oldridge J., Pelchen-Matthews A., Klasse P.J., Tran T., Brass L.F., et al. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol 1997, 139:651-664.
78. Silva C.M., Ribeiro A.J., Figueiredo I.V., Goncalves A.R., Veiga F. Alginate microspheres prepared by internal gelation: development and effect on insulin stability. Int J Pharm 2006, 311:1-10.
79. Polyak B., Geresh S., Marks R.S. Synthesis and characterization of a biotin-alginate conjugate and its application in a biosensor construction. Biomacromolecules 2004, 5:389-396.